PAVM Stock Summary and Trading Ideas (Pavmed | NASDAQ:PAVM)

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

Pavmed trades on the NASDAQ stock market under the symbol PAVM.

As of February 25, 2026, PAVM stock price climbed to $10.10 with 18,313 million shares trading.

PAVM has a beta of 1.28, meaning it tends to be more sensitive to market movements. PAVM has a correlation of 0.07 to the broad based SPY ETF.

PAVM has a market cap of $9.30 million. This is considered a Sub-Micro Cap stock.

Last quarter Pavmed reported $5,000 in Revenue and -$.60 earnings per share. This fell short of revenue expectation by $-7,500 and exceeded earnings estimates by $5.40.

In the last 3 years, PAVM traded as high as $280.91 and as low as $6.00.

The top ETF exchange traded funds that PAVM belongs to (by Net Assets): VXF.

PAVM has underperformed the market in the last year with a price return of -58.0% while the SPY ETF gained +17.1%. However, in the short term, PAVM had mixed performance relative to the market. It has outperformed in the last 3 months, returning +4.1% vs +3.8% return in SPY. But in the last 2 weeks, PAVM shares have been beat by the market, returning -7.8% compared to an SPY return of 0.0%.

PAVM support price is $9.18 and resistance is $10.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PAVM shares will trade within this expected range on the day.